ALK Fusion Detection in Circulating Free DNA: Finding an Important Needle in the Haystack

ALK rearrangements have emerged as important therapeutic targets in oncology. This commentary, in light of recently reported cases, discusses the emerging role of liquid biopsies in molecular testing and new therapeutic options for oncology patients.

Detalles Bibliográficos
Autores principales: Mooradian, Meghan J., Gainor, Justin F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2017
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507656/
https://www.ncbi.nlm.nih.gov/pubmed/28642334
http://dx.doi.org/10.1634/theoncologist.2017-0178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507656/
https://www.ncbi.nlm.nih.gov/pubmed/28642334
http://dx.doi.org/10.1634/theoncologist.2017-0178

Ejemplares similares